Adipocyte-Secreted IL-6 Sensitizes Macrophages to IL-4 Signaling
Diabetes · 01.03.2023 · 72 (3) · 367-374
DOI: 10.2337/db22-0444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 30.11.2022. Verfasst von Danny Luan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine/NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY. Hauptthemen laut MEDLINE: Interleukin-6, Insulin Resistance. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Austrian Science Fund FWF, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Complex bidirectional cross talk between adipocytes and adipose tissue immune cells plays an important role in regulating adipose function, inflammation, and insulin responsiveness. Adipocytes secrete the pleiotropic cytokine IL-6 in response to both inflammatory and catabolic stimuli. Previous studies have suggested that IL-6 secretion from adipocytes in obesity may promote adipose tissue inflammation. Here, we investigated catabolic stimulation of adipocyte IL-6 secretion and its impact on adipose tissue immune cells. In obesity, catecholamine resistance reduces cAMP-driven adipocyte IL-6 secretion in response to catabolic signals. By restoring adipocyte catecholamine sensitivity in obese adipocytes, amlexanox stimulates adipocyte-specific IL-6 secretion. We report that in this context, adipocyte-secreted IL-6 activates local macrophage STAT3 to promote Il4ra expression, thereby sensitizing them to IL-4 signaling and promoting an anti-inflammatory gene expression pattern. Supporting a paracrine adipocyte to macrophage mechanism, these effects could be recapitulated using adipocyte conditioned media to pretreat bone marrow–derived macrophages prior to polarization with IL-4. The effects of IL-6 signaling in adipose tissue are complex and context specific. These results suggest that cAMP-driven IL-6 secretion from adipocytes sensitizes adipose tissue macrophages to IL-4 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine/NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY.
- Life Sciences Institute, University of Michigan, Ann Arbor, MI.
- Division of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA.
- Weill Center for Metabolic Health, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Weill Cornell Medicine, New York, NY.
ORCID-Profile: Shannon M Reilly
Förderung
- Austrian Science Fund FWF
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
- American Diabetes Association
- University of Michigan
- Perrigo Undergraduate Summer Fellowship
- Austrian Science Fund
Zitieren
APA
Luan, D., Dadpey, B., Zaid, J., Bridge-Comer, P. E., DeLuca, J. H., Xia, W., Castle, J., & Reilly, S. M. (2023). Adipocyte-Secreted IL-6 Sensitizes Macrophages to IL-4 Signaling. Diabetes, 72(3), 367-374. https://doi.org/10.2337/db22-0444
Vancouver
Luan D, Dadpey B, Zaid J, Bridge-Comer PE, DeLuca JH, Xia W, et al. Adipocyte-Secreted IL-6 Sensitizes Macrophages to IL-4 Signaling. Diabetes. 2023;72(3):367-374. doi:10.2337/db22-0444
BibTeX
@article{Luan2023,
author = {Luan, Danny and Dadpey, Benyamin and Zaid, Jessica and Bridge-Comer, Pania E and DeLuca, Julia H and Xia, Wenmin and Castle, Joshua and Reilly, Shannon M},
title = {Adipocyte-Secreted IL-6 Sensitizes Macrophages to IL-4 Signaling},
journal = {Diabetes},
year = {2023},
volume = {72},
number = {3},
pages = {367--374},
doi = {10.2337/db22-0444}
}
EUVIMED